These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21598008)

  • 61. Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice.
    Bourque M; Morissette M; Al Sweidi S; Caruso D; Melcangi RC; Di Paolo T
    Neuroendocrinology; 2016; 103(3-4):300-14. PubMed ID: 26227546
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.
    Yano R; Yokoyama H; Kuroiwa H; Kato H; Araki T
    J Mol Neurosci; 2009 Sep; 39(1-2):211-9. PubMed ID: 19199078
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
    Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
    Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
    Aguirre P; Mena NP; Carrasco CM; Muñoz Y; Pérez-Henríquez P; Morales RA; Cassels BK; Méndez-Gálvez C; García-Beltrán O; González-Billault C; Núñez MT
    PLoS One; 2015; 10(12):e0144848. PubMed ID: 26658949
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice.
    Obuchowicz E; Antkiewicz-Michaluk L; Romańska I; Herman ZS
    J Neural Transm (Vienna); 2003 Dec; 110(12):1375-91. PubMed ID: 14666410
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease.
    Ardah MT; Bharathan G; Kitada T; Haque ME
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172035
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
    Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
    Abdel-Wahab MH
    J Biochem Mol Toxicol; 2005; 19(1):32-41. PubMed ID: 15736157
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson's Disease via Peroxisome Proliferator-Activated Receptorα.
    Prorok T; Jana M; Patel D; Pahan K
    Neurochem Res; 2019 Apr; 44(4):751-762. PubMed ID: 30612307
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
    Quik M; Chen L; Parameswaran N; Xie X; Langston JW; McCallum SE
    J Neurosci; 2006 Apr; 26(17):4681-9. PubMed ID: 16641249
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY; Lee MK; Hong JT
    Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.
    Gilad GM; Gilad VH; Finberg JP; Rabey JM
    Neurochem Res; 2005; 30(6-7):713-9. PubMed ID: 16187208
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
    Jung HW; Son HY; Jin GZ; Park YK
    Cell Biochem Funct; 2010 Apr; 28(3):217-23. PubMed ID: 20186864
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Restoration of intestinal function in an MPTP model of Parkinson's Disease.
    Ellett LJ; Hung LW; Munckton R; Sherratt NA; Culvenor J; Grubman A; Furness JB; White AR; Finkelstein DI; Barnham KJ; Lawson VA
    Sci Rep; 2016 Jul; 6():30269. PubMed ID: 27471168
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice.
    Kavitha M; Nataraj J; Essa MM; Memon MA; Manivasagam T
    Chem Biol Interact; 2013 Nov; 206(2):239-47. PubMed ID: 24095822
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
    J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
    [TBL] [Abstract][Full Text] [Related]  

  • 80. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
    Bao XQ; Kong XC; Qian C; Zhang D
    Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.